Stock NGEN NERVGEN PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart NervGen Pharma Corp.

Equities

NGEN

CA64082X2032

Market Closed - Toronto S.E.
Other stock markets
 15:59:59 2024-05-31 EDT 		5-day change 1st Jan Change
1.95 CAD -2.50% Intraday chart for NervGen Pharma Corp. -5.34% -27.78%
05-07 Nervgen Pharma Corp. Announces That Bill Radvak, Nervgen's Current Chairman and Co-Founder Will Not Stand for Re-Election and Will Transition to A Continuing Role as an Advisor to the Board CI
04-17 NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NERVGEN PHARMA CORP.
Other Biotechnology & Medical Research
-2.50%-5.34%-27.78%+12.07%+26.62% 102M - - -
  1. Stock Market
  2. Equities
  3. NGEN Stock
  4. Charts NervGen Pharma Corp.
  5. Relative Strength Chart